Caricamento...
Zn(II)-curc targets p53 in thyroid cancer cells
TP53 mutation is a common event in many cancers, including thyroid carcinoma. Defective p53 activity promotes cancer resistance to therapies and a more malignant phenotype, acquiring oncogenic functions. Rescuing the function of mutant p53 (mutp53) protein is an attractive anticancer therapeutic str...
Salvato in:
| Pubblicato in: | Int J Oncol |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
D.A. Spandidos
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4583539/ https://ncbi.nlm.nih.gov/pubmed/26314369 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijo.2015.3125 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|